Paradigms of vascularization in melanoma: Clinical significance and potential for therapeutic targeting
Melanoma is the most aggressive form of skin cancer. Malignant melanoma in particular has a poor prognosis and although treatment has improved, drug resistance continues to be a challenge. Angiogenesis, the formation of blood vessels from existing microvessels, precedes the progression of melanoma f...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-07-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332220303279 |
id |
doaj-2c53e45c6014412e96c0d5576cb0075d |
---|---|
record_format |
Article |
spelling |
doaj-2c53e45c6014412e96c0d5576cb0075d2021-05-20T07:41:35ZengElsevierBiomedicine & Pharmacotherapy0753-33222020-07-01127110135Paradigms of vascularization in melanoma: Clinical significance and potential for therapeutic targetingPeace Mabeta0Corresponding author at: P/Bag X323, Angiogenesis Lab, Dept. of Physiology, Faculty of Health Sciences, University of Pretoria Pretoria, 0001, South Africa.; Angiogenesis Laboratory, Department of Physiology, Faculty of Health Sciences, University of Pretoria, Pretoria, South AfricaMelanoma is the most aggressive form of skin cancer. Malignant melanoma in particular has a poor prognosis and although treatment has improved, drug resistance continues to be a challenge. Angiogenesis, the formation of blood vessels from existing microvessels, precedes the progression of melanoma from a radial growth phase to a malignant phenotype. In addition, melanoma cells can form networks of vessel-like fluid conducting channels through vasculogenic mimicry (VM). Both angiogenesis and VM have been postulated to contribute to the development of resistance to treatment and to enable metastasis. Also, the metastatic spread of melanoma is highly dependent on lymphangiogenesis, the formation of lymphatic vessels from pre-existing vessels. Interestingly, the design and clinical testing of drugs that target VM and lymphangiogenesis lag behind that of angiogenesis inhibitors. Despite this, antiangiogenic drugs have not significantly improved the overall survival of melanoma patients, thus necessitating the targeting of alternative mechanisms. In this article, I review the roles of the three paradigms of tissue perfusion, namely, angiogenesis, VM and lymphangiogenesis, in promoting melanoma progression and metastasis. This article also explores the latest development and potential opportunities in the therapeutic targeting of these processes.http://www.sciencedirect.com/science/article/pii/S0753332220303279MelanomaMetastasisLymphangiogenesisAngiogenesisVasculogenic mimicry |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Peace Mabeta |
spellingShingle |
Peace Mabeta Paradigms of vascularization in melanoma: Clinical significance and potential for therapeutic targeting Biomedicine & Pharmacotherapy Melanoma Metastasis Lymphangiogenesis Angiogenesis Vasculogenic mimicry |
author_facet |
Peace Mabeta |
author_sort |
Peace Mabeta |
title |
Paradigms of vascularization in melanoma: Clinical significance and potential for therapeutic targeting |
title_short |
Paradigms of vascularization in melanoma: Clinical significance and potential for therapeutic targeting |
title_full |
Paradigms of vascularization in melanoma: Clinical significance and potential for therapeutic targeting |
title_fullStr |
Paradigms of vascularization in melanoma: Clinical significance and potential for therapeutic targeting |
title_full_unstemmed |
Paradigms of vascularization in melanoma: Clinical significance and potential for therapeutic targeting |
title_sort |
paradigms of vascularization in melanoma: clinical significance and potential for therapeutic targeting |
publisher |
Elsevier |
series |
Biomedicine & Pharmacotherapy |
issn |
0753-3322 |
publishDate |
2020-07-01 |
description |
Melanoma is the most aggressive form of skin cancer. Malignant melanoma in particular has a poor prognosis and although treatment has improved, drug resistance continues to be a challenge. Angiogenesis, the formation of blood vessels from existing microvessels, precedes the progression of melanoma from a radial growth phase to a malignant phenotype. In addition, melanoma cells can form networks of vessel-like fluid conducting channels through vasculogenic mimicry (VM). Both angiogenesis and VM have been postulated to contribute to the development of resistance to treatment and to enable metastasis. Also, the metastatic spread of melanoma is highly dependent on lymphangiogenesis, the formation of lymphatic vessels from pre-existing vessels. Interestingly, the design and clinical testing of drugs that target VM and lymphangiogenesis lag behind that of angiogenesis inhibitors. Despite this, antiangiogenic drugs have not significantly improved the overall survival of melanoma patients, thus necessitating the targeting of alternative mechanisms. In this article, I review the roles of the three paradigms of tissue perfusion, namely, angiogenesis, VM and lymphangiogenesis, in promoting melanoma progression and metastasis. This article also explores the latest development and potential opportunities in the therapeutic targeting of these processes. |
topic |
Melanoma Metastasis Lymphangiogenesis Angiogenesis Vasculogenic mimicry |
url |
http://www.sciencedirect.com/science/article/pii/S0753332220303279 |
work_keys_str_mv |
AT peacemabeta paradigmsofvascularizationinmelanomaclinicalsignificanceandpotentialfortherapeutictargeting |
_version_ |
1721434971777794048 |